Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, Adam P Dicker & Robert B Den. (2014) Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?. Expert Review of Anticancer Therapy 14:1, pages 39-50.
Read now
Read now
Articles from other publishers (27)
Francesco Fiz, Mauro Iori, Federica Fioroni, Matteo Biroli, Giuseppe Roberto D’Agostino, Fabrizia Gelardi, Paola Anna Erba, Annibale Versari, Arturo Chiti & Martina Sollini. 2020. Nuclear Oncology. Nuclear Oncology
1
40
.
Francesco Fiz, Mauro Iori, Federica Fioroni, Matteo Biroli, Giuseppe Roberto D’Agostino, Fabrizia Gelardi, Paola Anna Erba, Annibale Versari, Arturo Chiti & Martina Sollini. 2020. Nuclear Oncology. Nuclear Oncology
1
40
.
Francesco Fiz, Mauro Iori, Federica Fioroni, Matteo Biroli, Giuseppe Roberto D’Agostino, Fabrizia Gelardi, Paola A. Erba, Annibale Versari, Arturo Chiti & Martina Sollini. 2022. Nuclear Oncology. Nuclear Oncology
1687
1726
.
Tonghe Wang, Jun Zhou, Sibo Tian, Yinan Wang, Pretesh Patel, Ashesh B. Jani, Katja M. Langen, Walter J. Curran, Tian Liu & Xiaofeng Yang. (2020) A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy. The British Journal of Radiology 93:1107, pages 20190845.
Crossref
Crossref
Tonghe Wang, Robert H. Press, Matt Giles, Ashesh B. Jani, Peter Rossi, Yang Lei, Walter J. Curran, Pretesh Patel, Tian Liu & Xiaofeng Yang. (2019) Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy. The British Journal of Radiology 92:1097, pages 20190089.
Crossref
Crossref
Barbara Alicja Jereczek-Fossa, Damaris Patricia Rojas, Dario Zerini, Cristiana Fodor, Anna Viola, Giuseppe Fanetti, Stefania Volpe, Rosa Luraschi, Alessia Bazani, Elena Rondi, Federica Cattani, Andrea Vavassori, Cristina Garibaldi, Sarah Alessi, Paola Pricolo, Giuseppe Petralia, Gabriele Cozzi, Ottavio De Cobelli, Gennaro Musi, Roberto Orecchia, Giulia Marvaso & Delia Ciardo. (2019) Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT). The British Journal of Radiology 92:1094, pages 20180494.
Crossref
Crossref
Thorsten Frenzel, Milena Tienken, Merve Abel, Christoph Berliner, Susanne Klutmann, Dirk Beyersdorff, Rudolf Schwarz, Andreas Krüll & Peter Bannas. (2018) The impact of [68Ga]PSMA I&T PET/CT on radiotherapy planning in patients with prostate cancerDer Einfluss von [68Ga]-PSMA-I&T-PET/CT auf die Radiotherapieplanung bei Patienten mit Prostatakarzinom. Strahlentherapie und Onkologie 194:7, pages 646-654.
Crossref
Crossref
Marsha Schlenter, Vanessa Berneking, Barabara Krenkel, Felix M. Mottaghy, Thomas-Alexander Vögeli, Michael J. Eble & Michael Pinkawa. (2018) Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CTIntensitätsmodulierte Radiotherapie des Prostatakarzinoms mit simultanem integriertem Boost nach molekularer Bildgebung mit 18F-Cholin-PET/CT. Strahlentherapie und Onkologie 194:7, pages 638-645.
Crossref
Crossref
Giampiero Giovacchini, Elisabetta Giovannini, Rossella Leoncini, Mattia Riondato & Andrea Ciarmiello. (2017) PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies. European Journal of Nuclear Medicine and Molecular Imaging 44:10, pages 1751-1776.
Crossref
Crossref
Benedikt J. Schwaiger, David L. Kopperdahl, Lorenzo Nardo, Luca Facchetti, Alexandra S. Gersing, Jan Neumann, Kwang J. Lee, Tony M. Keaveny & Thomas M. Link. (2017) Vertebral and femoral bone mineral density and bone strength in prostate cancer patients assessed in phantomless PET/CT examinations. Bone 101, pages 62-69.
Crossref
Crossref
Giulia Marvaso, Barbara A. Jereczek-Fossa, Giulia Riva, Camilla Bassi, Cristiana Fodor, Delia Ciardo, Raffaella Cambria, Floriana Pansini, Dario Zerini, Paolo De Marco, Federica Cattani, Ottavio De Cobelli & Roberto Orecchia. (2017) High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy Approach. Clinical Genitourinary Cancer 15:3, pages 376-383.
Crossref
Crossref
Elena Incerti, Paola Mapelli & Maria Picchio. 2017. Bone Metastases from Prostate Cancer. Bone Metastases from Prostate Cancer
75
85
.
Maria Picchio, Elena Incerti & Nadia Di Muzio. 2017. Basic Science of PET Imaging. Basic Science of PET Imaging
577
608
.
Michael Pinkawa, Carolina Ribbing, Victoria Djukic, Jens Klotz, Richard Holy & Michael J. Eble. (2015) Early hematologic changes during prostate cancer radiotherapy predictive for late urinary and bowel toxicityFrühe hämatologische Veränderungen während der Radiotherapie beim Prostatakarzinom prädiktiv für späte Miktions- und Darmbeschwerden. Strahlentherapie und Onkologie 191:10, pages 771-777.
Crossref
Crossref
Minh Tam Truong & Nataliya Kovalchuk. (2015) Radiotherapy Planning. PET Clinics 10:2, pages 279-296.
Crossref
Crossref
Barbara Alicja Jereczek-Fossa, Marcello Rodari, Maria Bonora, Paola Fanti, Cristiana Fodor, Giovanna Pepe, Egesta Lopci, Dario Zerini, Barbara Vischioni, Guido Baroni, Deliu Victor Matei, Ottavio De Cobelli, Arturo Chiti & Roberto Orecchia. (2014) [11C]Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy. Clinical Genitourinary Cancer 12:3, pages 155-159.
Crossref
Crossref
Michael Pinkawa, Victoria Djukic, Jens Klotz, Dalma Petz, Marc D Piroth, Richard Holy & Michael J Eble. (2014) Hematologic changes during prostate cancer radiation therapy are dependent on the treatment volume. Future Oncology 10:5, pages 835-843.
Crossref
Crossref
Michael Orth, Kirsten Lauber, Maximilian Niyazi, Anna A. Friedl, Minglun Li, Cornelius Maihöfer, Lars Schüttrumpf, Anne Ernst, Olivier M. Niemöller & Claus Belka. (2013) Current concepts in clinical radiation oncology. Radiation and Environmental Biophysics 53:1, pages 1-29.
Crossref
Crossref
Nicholas G. Zaorsky, Amy S. Harrison, Edouard J. Trabulsi, Leonard G. Gomella, Timothy N. Showalter, Mark D. Hurwitz, Adam P. Dicker & Robert B. Den. (2013) Evolution of advanced technologies in prostate cancer radiotherapy. Nature Reviews Urology 10:10, pages 565-579.
Crossref
Crossref
Michael Pinkawa, Jens Klotz, Victoria Djukic, Carolin Schubert, Nuria Escobar-Corral, Mariana Caffaro, Marc D. Piroth, Richard Holy & Michael J. Eble. (2013) Learning Curve in the Application of a Hydrogel Spacer to Protect the Rectal Wall During Radiotherapy of Localized Prostate Cancer. Urology 82:4, pages 963-968.
Crossref
Crossref
Y. Moussaid, G. Bonardel, J. Jacob, D. Métivier, É. Gontier, O. Bauduceau, X. Durand, M. Fayolle, A. Houlgatte, H. Foehrenbach, L. Védrine & C. Chargari. (2013) Expérience monocentrique de la tomographie par émission de positons à la (18F)-fluorocholine : analyse de son impact sur les indications de traitement local de rattrapage dans la prise en charge des adénocarcinomes prostatiques. Cancer/Radiothérapie 17:4, pages 259-264.
Crossref
Crossref
Mark V. Mishra & Timothy N. Showalter. (2013) Pushing the Limits of Radiation Therapy for Prostate Cancer: Where Do We Go Next?. Seminars in Oncology 40:3, pages 297-307.
Crossref
Crossref
Glenn Bauman, Masoom Haider, Uulke A. Van der Heide & Cynthia Ménard. (2013) Boosting imaging defined dominant prostatic tumors: A systematic review. Radiotherapy and Oncology 107:3, pages 274-281.
Crossref
Crossref
Michael Pinkawa, Marc D Piroth, Richard Holy, Jens Klotz, Victoria Djukic, Nuria Escobar Corral, Mariana Caffaro, Oliver H Winz, Thomas Krohn, Felix M Mottaghy & Michael J Eble. (2012) Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boost. Radiation Oncology 7:1.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Urology 22:4, pages 336-345.
Crossref
Crossref
Mingqian Tan, Susan M. Burden-Gulley, Wen Li, Xueming Wu, Daniel Lindner, Susann M. Brady-Kalnay, Vikas Gulani & Zheng-Rong Lu. (2011) MR Molecular Imaging of Prostate Cancer with a Peptide-Targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model. Pharmaceutical Research 29:4, pages 953-960.
Crossref
Crossref
Minh Tam Truong & Rathan M. Subramaniam. 2012. PET-CT and PET-MRI in Oncology. PET-CT and PET-MRI in Oncology
337
377
.